In the relma-cel study, the expression levels of tumor-associated fibroblast markers (AP, TNC, CSPG4, PDGFRA, S100A4, ASPN, STC1, and ITGAM) were higher in the patients with PR than with CR [59]. This evidence concerns the gene STC1 and neoplasm.